Many Pediatric Autoimmune Disorders Share Altered Genetic Loci, Study Finds

Aug 24, 2015

|

NEW YORK (GenomeWeb) – Many pediatric autoimmune disorders have genetic alterations at shared sites, according to a meta-analysis performed by researchers from Children's Hospital of Philadelphia and elsewhere.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Free of Influence

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

Avoiding the MARCH1 to 1-Mar Change

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

Nature Papers Reveal Tuatara Genome, Cell Populations Involved in Lupus

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

Overlooked Expertise

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.

Featured White Papers

Type 1 Interferon Gene Expression Analysis: Precision Medicine in Lupus

Aug

13

Featured Webinar

Single-Cell and Spatial Transcriptomic Profiling of the Septic Kidney

This webinar will discuss a study that combined single-cell gene expression and spatial gene expression to understand the evolution of sepsis in the kidney at the cellular and molecular level.

Aug

24

Featured Webinar

Utility of Novel RNA-Based Tools in Oncology Drug Development

This webinar, Part 1 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss how gene expression signatures can accelerate (and rehabilitate) drug programs, define targeted patient populations, expand drug indications, and improve clinical success.

Aug

27

Featured Webinar

CRISPR/Cas9 Screens to Investigate Mechanisms of Cancer Drug Resistance

Over 70 percent of breast cancers are estrogen receptor positive and are treated with endocrine therapy.

Sep

03

Featured Webinar

Implementation of Preemptive PGx Screening in a World-Class Personalized Medicine Program

This webinar will provide an overview of how the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado implemented a preemptive pharmacogenomic screening program via a large-scale research biobank and a robust biocomputing system.

Menu

Many Pediatric Autoimmune Disorders Share Altered Genetic Loci, Study Finds

To read the full story....

Breaking News

Fluidigm Q2 Revenues Fall 8 Percent

NantHealth Q2 Revenues Decline 12 Percent

Twist Bioscience Q3 Revenues Grow 56 percent

Guardant Health Q2 Revenues Rise 23 Percent

Illumina Q2 Revenues Drop 25 Percent

Personalis Q2 Revenues Up 23 Percent

The Scan

Free of Influence

Avoiding the MARCH1 to 1-Mar Change

Nature Papers Reveal Tuatara Genome, Cell Populations Involved in Lupus

Overlooked Expertise

Featured White Papers

Single-Cell and Spatial Transcriptomic Profiling of the Septic Kidney

Utility of Novel RNA-Based Tools in Oncology Drug Development

CRISPR/Cas9 Screens to Investigate Mechanisms of Cancer Drug Resistance

Implementation of Preemptive PGx Screening in a World-Class Personalized Medicine Program

What's Popular?

Sequencing Uncovers Mutation, Treatment for Rare Genetic Autoimmune Disorder

Scipher Medicine to Launch PrismRA Anti-TNF Response Predictor Following Positive Data Publication

Sponsorships